Ali Behbahani, a director at $ADAP, sold 14,671,794 shares of the company on 08-18-2025 for an estimated $176,061. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $ADAP stock.
$ADAP Insider Trading Activity
$ADAP insiders have traded $ADAP stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ADAP stock by insiders over the last 6 months:
- CAPITAL, LLC ECOR1 has made 0 purchases and 3 sales selling 64,052,538 shares for an estimated $6,890,235.
- ALI BEHBAHANI has made 0 purchases and 2 sales selling 19,500,000 shares for an estimated $229,171.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ADAP Hedge Fund Activity
We have seen 20 institutional investors add shares of $ADAP stock to their portfolio, and 49 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAILLIE GIFFORD & CO removed 11,819,095 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,328,361
- PFM HEALTH SCIENCES, LP removed 4,871,969 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $959,777
- TWO SEAS CAPITAL LP added 2,051,016 shares (+10.0%) to their portfolio in Q2 2025, for an estimated $491,628
- MORGAN STANLEY added 1,516,321 shares (+55.8%) to their portfolio in Q2 2025, for an estimated $363,462
- FMR LLC removed 1,290,611 shares (-73.5%) from their portfolio in Q2 2025, for an estimated $309,359
- UBS GROUP AG removed 949,782 shares (-93.8%) from their portfolio in Q2 2025, for an estimated $227,662
- JPMORGAN CHASE & CO removed 859,549 shares (-97.4%) from their portfolio in Q2 2025, for an estimated $206,033
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ADAP Analyst Ratings
Wall Street analysts have issued reports on $ADAP in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 05/14/2025
- Guggenheim issued a "Buy" rating on 03/26/2025
- Scotiabank issued a "Sector Outperform" rating on 03/21/2025
To track analyst ratings and price targets for $ADAP, check out Quiver Quantitative's $ADAP forecast page.
$ADAP Price Targets
Multiple analysts have issued price targets for $ADAP recently. We have seen 6 analysts offer price targets for $ADAP in the last 6 months, with a median target of $1.2.
Here are some recent targets:
- Graig Suvannavejh from Mizuho set a target price of $0.5 on 06/26/2025
- Peter Lawson from Barclays set a target price of $0.46 on 05/14/2025
- Yanan Zhu from Wells Fargo set a target price of $1.0 on 05/14/2025
- Arthur He from HC Wainwright & Co. set a target price of $3.0 on 04/01/2025
- Michael Schmidt from Guggenheim set a target price of $1.75 on 03/26/2025
- George Farmer from Scotiabank set a target price of $1.4 on 03/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
